First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping

Arianne Clare Agdamag; Andrew Shaffer; Ranjit John; Andrew S. Wechsler; Marc Pritzker; Meg Fraser; Cindy M. Martin; Rebecca Cogswell; Tamas Alexy

doi:10.1016/j.athoracsur.2020.11.052

First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping

Arianne Clare Agdamag, Andrew Shaffer, Ranjit John, Andrew S. Wechsler, Marc Pritzker, Meg Fraser, Cindy M. Martin, Rebecca Cogswell, Tamas Alexy

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

The Revivent TC System (BioVentrix Inc, San Ramon, CA) enables a less invasive approach for left ventricular reshaping and scar exclusion in selected patients with ischemic cardiomyopathy. Although the system is designed to improve quality of life and to promote reverse remodeling, patients can still progress to end-stage heart failure requiring advanced therapies. This report describes a case of left ventricular assist device surgery in a patient 16 months after Revivent System implantation. The planning process and surgical technique proved to be complex. This case report can help provide guidance to advanced heart failure teams who encounter patients with the Revivent System who require left ventricular assist device support.

Original language	English (US)
Pages (from-to)	e123-e126
Journal	Annals of Thoracic Surgery
Volume	112
Issue number	2
DOIs	https://doi.org/10.1016/j.athoracsur.2020.11.052
State	Published - Aug 2021

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.athoracsur.2020.11.052

Cite this

@article{d579f81bde7243a1b33d6bcf8df22e7a,

title = "First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping",

abstract = "The Revivent TC System (BioVentrix Inc, San Ramon, CA) enables a less invasive approach for left ventricular reshaping and scar exclusion in selected patients with ischemic cardiomyopathy. Although the system is designed to improve quality of life and to promote reverse remodeling, patients can still progress to end-stage heart failure requiring advanced therapies. This report describes a case of left ventricular assist device surgery in a patient 16 months after Revivent System implantation. The planning process and surgical technique proved to be complex. This case report can help provide guidance to advanced heart failure teams who encounter patients with the Revivent System who require left ventricular assist device support.",

author = "Agdamag, {Arianne Clare} and Andrew Shaffer and Ranjit John and Wechsler, {Andrew S.} and Marc Pritzker and Meg Fraser and Martin, {Cindy M.} and Rebecca Cogswell and Tamas Alexy",

note = "Publisher Copyright: {\textcopyright} 2021 The Society of Thoracic Surgeons",

year = "2021",

month = aug,

doi = "10.1016/j.athoracsur.2020.11.052",

language = "English (US)",

volume = "112",

pages = "e123--e126",

journal = "Annals of Thoracic Surgery",

issn = "0003-4975",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping

AU - Agdamag, Arianne Clare

AU - Shaffer, Andrew

AU - John, Ranjit

AU - Wechsler, Andrew S.

AU - Pritzker, Marc

AU - Fraser, Meg

AU - Martin, Cindy M.

AU - Cogswell, Rebecca

AU - Alexy, Tamas

PY - 2021/8

Y1 - 2021/8

N2 - The Revivent TC System (BioVentrix Inc, San Ramon, CA) enables a less invasive approach for left ventricular reshaping and scar exclusion in selected patients with ischemic cardiomyopathy. Although the system is designed to improve quality of life and to promote reverse remodeling, patients can still progress to end-stage heart failure requiring advanced therapies. This report describes a case of left ventricular assist device surgery in a patient 16 months after Revivent System implantation. The planning process and surgical technique proved to be complex. This case report can help provide guidance to advanced heart failure teams who encounter patients with the Revivent System who require left ventricular assist device support.

AB - The Revivent TC System (BioVentrix Inc, San Ramon, CA) enables a less invasive approach for left ventricular reshaping and scar exclusion in selected patients with ischemic cardiomyopathy. Although the system is designed to improve quality of life and to promote reverse remodeling, patients can still progress to end-stage heart failure requiring advanced therapies. This report describes a case of left ventricular assist device surgery in a patient 16 months after Revivent System implantation. The planning process and surgical technique proved to be complex. This case report can help provide guidance to advanced heart failure teams who encounter patients with the Revivent System who require left ventricular assist device support.

UR - http://www.scopus.com/inward/record.url?scp=85110758404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85110758404&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2020.11.052

DO - 10.1016/j.athoracsur.2020.11.052

M3 - Article

C2 - 33444578

AN - SCOPUS:85110758404

SN - 0003-4975

VL - 112

SP - e123-e126

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

IS - 2

ER -

First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this